Konrad P. Wirz
Directeur Financier/CFO chez Speedel Pharma AG
Profil
Konrad P.
Wirz is Chief Financial Officer of Speedel Pharma AG.
Previously, he was Chief Financial Officer of Sandoz Agro, Inc., Northrup King (US), Schweizerhall, and Actelion Ltd.
He has experience in the corporate valuations, controlling, and strategic financial planning.
Mr. Wirz holds a degree in Business Administration.
Postes actifs de Konrad P. Wirz
| Sociétés | Poste | Début |
|---|---|---|
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Directeur Financier/CFO | - |
Anciens postes connus de Konrad P. Wirz
| Sociétés | Poste | Fin |
|---|---|---|
| ACINO HOLDING AG | Directeur Financier/CFO | - |
| ACTELION | Directeur Financier/CFO | - |
Sandoz Agro, Inc.
 Sandoz Agro, Inc. Chemicals: AgriculturalProcess Industries Sandoz Agro, Inc. provides animal health support services and manufactures pesticides. The company was headquartered in Des Plaines, IL. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Sandoz Agro, Inc.
Sandoz Agro, Inc. Chemicals: AgriculturalProcess Industries Sandoz Agro, Inc. provides animal health support services and manufactures pesticides. The company was headquartered in Des Plaines, IL. | Process Industries |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Health Technology |
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |